Abstract

Objective: To promote guidelines for health care providers on the key aspects of HPV infection and the management of HPV-related disease in the new era of vaccine availability. Evidence: Medline and Cochrane databases were searched for articles from January 1995 to March 2007 on subjects related to HPV infection, HPV vaccination, HPV-related disease, Pap testing, and specific consideration of management. Values: The quality of evidence is rated using the criteria described in the report of the Canadian Task Force on the Periodic Health Examination. Recommendations for practice are ranked according to the method described in this report. Sponsors: The development of this consensus guideline was supported by unrestricted educational grants from Cytyc Canada, Digene Corporation, Graceway Canada, GlaxoSmithKline Inc, Merck Frosst Canada Ltd, and Roche Diagnostics Canada. Copyright © 2007 Society of Obstetricians and Gynaecologists of Canada.

Journal of Obstetrics and Gynaecology Canada, S1, 29, 8 Supplement3
(Money) VancouverBCCanada (Roy) Quebec CityQCCanada (Scrivener, Lalonde, Senikas) OttawaONCanada (Allen, Murphy, Shier) TorontoONCanada (Brewer) QuispamsisNBCanada (Bryson, Evans, Jamieson) KingstonONCanada (Frappier, Provencher, Steben) MontrealQCCanada (Lynde) MarkhamONCanada (Lerch) Public Health Agency of Canada, Ottawa, ON, Canada